Abstract

HSD15 Investigating the Impact of Early Versus Late Diagnosis in Fabry Disease on Healthcare Resource Utilization and Associated Costs in Greece

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Impact of Age on Healthcare Costs and Resource Utilization in Patients with Crohnʼs Disease from a Payer Perspective
O Dabbous ... R Arjunji
The American Journal of Gastroenterology | VOL. 101
O Dabbous, et. al.O Dabbous ... R Arjunji
01 Sep 2006
Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease
Aaron King ... Chioma Uzoigwe
Current medical research and opinion | VOL. 38
Aaron King, et. al.Aaron King ... Chioma Uzoigwe
29 Sep 2022
Health Care Costs and Resource Utilization Among Patients With Crohn's Disease With and Without Perianal Fistula.
Grace Chen ... Qasim Rana Khan
Inflammatory bowel diseases | VOL. 28
Grace Chen, et. al.Grace Chen ... Qasim Rana Khan
15 Sep 2021
Cost and utilisation of healthcare resources during rehabilitation after ankle fracture are not linked to health insurance, income, gender, or pain: an observational study
Chung-Wei Christine Lin ... Kathryn M Refshauge
Australian Journal of Physiotherapy | VOL. 54
Chung-Wei Christine Lin, et. al.Chung-Wei Christine Lin ... Kathryn M Refshauge
01 Jan 2008
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
EQ-5D-5L population scores in mainland China: results from a nationally representative survey 2021
Qiang Yao ... Chaojie Liu
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Qiang Yao, et. al.Qiang Yao ... Chaojie Liu
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
View more papers